Debanga Sarma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Debanga Sarma has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Mandeep Phukan
Department of Urology and Renal Transplant, Gauhati Medical College and Hospital, Guwahati, India
2 shared publications - Puskal Kumar Bagchi
Department of Urology and Renal Transplant, Gauhati Medical College and Hospital, Guwahati, India
2 shared publications - Sasanka Kumar Barua
Department of Urology, Gauhati Medical College, Guwahati, Assam, India
2 shared publications Tp Rajeev
Department of Urology, Gauhati Medical College, Bhangagarh, Guwahati, Assam, India
2 shared publications- Arnabjyoti Deva Sarma
Faculty of Allied and Healthcare Sciences, Assam down town University, Guwahati, India
1 shared publication - Dinesh Kumar
GNA School of Pharmacy, GNA University, Phagwara, India
1 shared publication
Latest Publications
- Open Access
- 14 August 2026
- Published by Springer Nature in Inflammation
- Vol. 49 (1)
Microbiome-derived Metabolites in Anti-inflammatory Therapy: from Mechanisms to Translational Potential
Chronic inflammation underlies autoimmune, metabolic, cardiovascular, and neurodegenerative disorders and remains difficult to manage because current anti-inflammatory therapies often have systemic adverse effects and variable clinical efficacy. This review synthesizes evidence on microbiome-associated metabolites relevant to inflammation, including short-chain fatty acids, microbial indole derivatives, secondary bile acids, polyamines, trimethylamine N-oxide, and selected host-microbe co-metabolites. These compounds regulate host immunity through G-protein-coupled receptors, nuclear receptors, epigenetic mechanisms, inflammasome regulation, and major inflammatory signaling pathways such as NF-kappaB, MAPK, and JAK-STAT. The translational potential of direct metabolite administration, prodrug design, microbiome engineering, dietary modulation, and targeted delivery systems is discussed alongside key limitations, including low bioavailability, context-dependent activity, interindividual microbiome variation, incomplete pharmacokinetic data, and the limited number of well-controlled human trials. Overall, microbiome-associated metabolites represent promising but still evolving therapeutic candidates; their clinical use requires stronger causal evidence, standardized formulations, safety evaluation, and disease-specific validation. Graphical Abstract Microbiome-associated metabolites, including short-chain fatty acids, microbial indole derivatives, secondary bile acids, and polyamines, contribute to epithelial homeostasis and regulate immune signaling through pathways such as NF-kappaB, MAPK, JAK-STAT, inflammasome activation, GPCR signaling, and epigenetic remodeling. Therapeutic strategies such as metabolite supplementation, prodrug design, microbiome engineering, and nano-delivery systems may enable targeted anti-inflammatory effects, but their clinical application remains dependent on stronger human evidence and standardized delivery approaches.
- 14 August 2026
- Published by Springer Nature in Inflammation
- Vol. 49 (1)
Open AccessMicrobiome-derived Metabolites in Anti-inflammatory Therapy: from Mechanisms to Translational Potential
Chronic inflammation underlies autoimmune, metabolic, cardiovascular, and neurodegenerative disorders and remains difficult to manage because current anti-inflammatory therapies often have systemic adverse effects and variable clinical efficacy. This review synthesizes evidence on microbiome-associated metabolites relevant to inflammation, including short-chain fatty acids, microbial indole derivatives, secondary bile acids, polyamines, trimethylamine N-oxide, and selected host-microbe co-metabolites. These compounds regulate host immunity through G-protein-coupled receptors, nuclear receptors, epigenetic mechanisms, inflammasome regulation, and major inflammatory signaling pathways such as NF-kappaB, MAPK, and JAK-STAT. The translational potential of direct metabolite administration, prodrug design, microbiome engineering, dietary modulation, and targeted delivery systems is discussed alongside key limitations, including low bioavailability, context-dependent activity, interindividual microbiome variation, incomplete pharmacokinetic data, and the limited number of well-controlled human trials. Overall, microbiome-associated metabolites represent promising but still evolving therapeutic candidates; their clinical use requires stronger causal evidence, standardized formulations, safety evaluation, and disease-specific validation. Graphical Abstract Microbiome-associated metabolites, including short-chain fatty acids, microbial indole derivatives, secondary bile acids, and polyamines, contribute to epithelial homeostasis and regulate immune signaling through pathways such as NF-kappaB, MAPK, JAK-STAT, inflammasome activation, GPCR signaling, and epigenetic remodeling. Therapeutic strategies such as metabolite supplementation, prodrug design, microbiome engineering, and nano-delivery systems may enable targeted anti-inflammatory effects, but their clinical application remains dependent on stronger human evidence and standardized delivery approaches.
- 9 December 2024
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 16 (4) , 848-852
Synovial Sarcoma of Testis: a Rare Tumour at an Uncommon Site—A Case Report
Neoplasms of testis are relatively rare with an incidence of approximately 1% of cancers in men diagnosed worldwide. Germ cell tumours form around more than 95% of testicular neoplasm. Primary synovial sarcoma of testis is exceedingly rare and soft tissue sarcoma forms around 1% of all adult malignancies. Among sarcomas, synovial sarcoma is about 5 to 10%. It is a mesenchymal tumour which affects children and young adults and mostly involves extremities. This is the second case being reported in the literature. We report the case of a 35-year-old man who presented with a left testicular mass and underwent radical high inguinal orchiectomy. Lost to follow-up, he returned with a recurrent mass in the left inguinoscrotal region. He underwent wide local excision with systemic chemotherapy (a combination of ifosfamide and doxorubicin)and radiotherapy postoperatively. He succumbed to the disease in a year. The prognosis is guarded as the optimal therapy is unknown.
- 9 December 2024
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 16 (4) , 848-852
Synovial Sarcoma of Testis: a Rare Tumour at an Uncommon Site—A Case Report
Neoplasms of testis are relatively rare with an incidence of approximately 1% of cancers in men diagnosed worldwide. Germ cell tumours form around more than 95% of testicular neoplasm. Primary synovial sarcoma of testis is exceedingly rare and soft tissue sarcoma forms around 1% of all adult malignancies. Among sarcomas, synovial sarcoma is about 5 to 10%. It is a mesenchymal tumour which affects children and young adults and mostly involves extremities. This is the second case being reported in the literature. We report the case of a 35-year-old man who presented with a left testicular mass and underwent radical high inguinal orchiectomy. Lost to follow-up, he returned with a recurrent mass in the left inguinoscrotal region. He underwent wide local excision with systemic chemotherapy (a combination of ifosfamide and doxorubicin)and radiotherapy postoperatively. He succumbed to the disease in a year. The prognosis is guarded as the optimal therapy is unknown.
- Open Access
- 27 August 2022
- Published by Springer Nature in Cureus
- Vol. 14 (8) , e28482
Renal Transplantation Could Reverse Dialysis-Associated Porphyria
Pseudoporphyria (PP) is a relatively infrequent, photodistributed bullous dermatosis that clinically, histopathologically, and immunologically resembles porphyria cutanea tarda (PCT), but is not accompanied by porphyrin abnormalities in the serum, urine, or stool. It was initially described in patients with renal failure on dialysis as 'bullous dermatosis of hemodialysis.' Pseudoporphyria has been seen in patients with end-stage renal disease on hemodialysis. No treatment has proved efficacious in the management of pseudoporphyria. However, N-acetylcysteine has been anecdotally reported to be effective in the management of hemodialysis-related pseudoporphyria and other porphyric diseases. Our patient had developed multiple skin lesions all over the body when hemodialysis started. The lesions were erythematous with fluid-filled vesicles, and bullae with cutaneous fragility that were evaluated and diagnosed as pseudoporphyria. The patient was treated with available all medication in the literature but was not relieved. However, all skin lesions completely healed within 22 days post renal transplantation. Renal transplantation proved to be the cure for dialysis-induced pseudoporphyria resistant to conventional drug therapy.
- 27 August 2022
- Published by Springer Nature in Cureus
- Vol. 14 (8) , e28482
Open AccessRenal Transplantation Could Reverse Dialysis-Associated Porphyria
Pseudoporphyria (PP) is a relatively infrequent, photodistributed bullous dermatosis that clinically, histopathologically, and immunologically resembles porphyria cutanea tarda (PCT), but is not accompanied by porphyrin abnormalities in the serum, urine, or stool. It was initially described in patients with renal failure on dialysis as 'bullous dermatosis of hemodialysis.' Pseudoporphyria has been seen in patients with end-stage renal disease on hemodialysis. No treatment has proved efficacious in the management of pseudoporphyria. However, N-acetylcysteine has been anecdotally reported to be effective in the management of hemodialysis-related pseudoporphyria and other porphyric diseases. Our patient had developed multiple skin lesions all over the body when hemodialysis started. The lesions were erythematous with fluid-filled vesicles, and bullae with cutaneous fragility that were evaluated and diagnosed as pseudoporphyria. The patient was treated with available all medication in the literature but was not relieved. However, all skin lesions completely healed within 22 days post renal transplantation. Renal transplantation proved to be the cure for dialysis-induced pseudoporphyria resistant to conventional drug therapy.
- Open Access
- 1 January 2013
- Published by Medknow in Urology Annals
- Vol. 5 (3) , 179-82
Role of primary chemotherapy in management of large tumors of undescended testis: Our experience
Objective: This study aimed to share our experience with tumors of undescended testis (UDT) and to assess the impact of primary cisplatin-based chemotherapy on such tumors. Materials and Methods: This study included the cases of tumor in UDT from February 2005 to December 2011. Evaluation of the cases was done with proper clinical examination and laboratory investigations along with tumor markers (alfa-feto protein, beta-human chorionic gonadotropin, lactate dehydrogenase) and contrast-enhanced computed tomography abdomen. Fine needle aspiration cytologywas done in all cases. Primary chemotherapy with three cycles of bleomycin, etoposide, and cisplatin regimen at three weekly intervals started in all cases. Response to treatment was seen after four weeks of the third cycle. Results: Fourteen cases (12.5%) of germ cell tumor in UDT out of 112 cases of germ cell tumor of the testis were included. The age ranged from 16-60 years. Histological diagnosis was pure seminoma in all cases. After three cycles of BEP regime, complete response was seen in 11 cases and partial response in three cases where the residual tumor was excised along with retroperitoneal lymph node dissection RPLND. Of the 14 cases, 13 were in regular follow-up and one was lost to follow-up. All on follow-up were doing well without recurrence till now. Conclusion: Surgical removal of the primary tumor in UDT with or without bulky metastasis is complicated. Primary chemotherapy with cisplatin-based regimen is a good option in such cases.
- 1 January 2013
- Published by Medknow in Urology Annals
- Vol. 5 (3) , 179-82
Open AccessRole of primary chemotherapy in management of large tumors of undescended testis: Our experience
Objective: This study aimed to share our experience with tumors of undescended testis (UDT) and to assess the impact of primary cisplatin-based chemotherapy on such tumors. Materials and Methods: This study included the cases of tumor in UDT from February 2005 to December 2011. Evaluation of the cases was done with proper clinical examination and laboratory investigations along with tumor markers (alfa-feto protein, beta-human chorionic gonadotropin, lactate dehydrogenase) and contrast-enhanced computed tomography abdomen. Fine needle aspiration cytologywas done in all cases. Primary chemotherapy with three cycles of bleomycin, etoposide, and cisplatin regimen at three weekly intervals started in all cases. Response to treatment was seen after four weeks of the third cycle. Results: Fourteen cases (12.5%) of germ cell tumor in UDT out of 112 cases of germ cell tumor of the testis were included. The age ranged from 16-60 years. Histological diagnosis was pure seminoma in all cases. After three cycles of BEP regime, complete response was seen in 11 cases and partial response in three cases where the residual tumor was excised along with retroperitoneal lymph node dissection RPLND. Of the 14 cases, 13 were in regular follow-up and one was lost to follow-up. All on follow-up were doing well without recurrence till now. Conclusion: Surgical removal of the primary tumor in UDT with or without bulky metastasis is complicated. Primary chemotherapy with cisplatin-based regimen is a good option in such cases.
- Open Access
- 1 January 2012
- Published by Medknow in Indian Journal of Urology
- Vol. 28 (4) , 414-7
Correlation between differential renal function estimation using CT-based functional renal parenchymal volume and 99m Tc - DTPA renal scan
Introduction and Objective: Nuclear renal scan is currently the gold standard imaging study to determine differential renal function. We propose helical CT as single modality for both the anatomical and functional evaluation of kidney with impaired function. In the present study renal parenchymal volume is measured and percent total renal volume is used as a surrogate marker for differential renal function. The objective of this study is to correlate between differential renal function estimation using CT-based renal parenchymal volume measurement with differential renal function estimation using 99m TC - DTPA renal scan. Materials and Methods: Twenty-one patients with unilateral obstructive uropathy were enrolled in this prospective comparative study. They were subjected to 99m Tc - DTPA renal scan and 64 slice helical CT scan which estimates the renal volume depending on the reconstruction of arterial phase images followed by volume rendering and percent renal volume was calculated. Percent renal volume was correlated with percent renal function, as determined by nuclear renal scan using Pearson coefficient. Results and Observation: A strong correlation is observed between percent renal volume and percent renal function in obstructed units (r = 0.828, P < 0.001) as well as in nonobstructed units (r = 0.827, P < 0.001). Conclusion: There is a strong correlation between percent renal volume determined by CT scan and percent renal function determined by 99m TC - DTPA renal scan both in obstructed and in normal units. CT-based percent renal volume can be used as a single radiological tests for both functional and anatomical assessment of impaired renal units.
- 1 January 2012
- Published by Medknow in Indian Journal of Urology
- Vol. 28 (4) , 414-7
Open AccessCorrelation between differential renal function estimation using CT-based functional renal parenchymal volume and 99m Tc - DTPA renal scan
Introduction and Objective: Nuclear renal scan is currently the gold standard imaging study to determine differential renal function. We propose helical CT as single modality for both the anatomical and functional evaluation of kidney with impaired function. In the present study renal parenchymal volume is measured and percent total renal volume is used as a surrogate marker for differential renal function. The objective of this study is to correlate between differential renal function estimation using CT-based renal parenchymal volume measurement with differential renal function estimation using 99m TC - DTPA renal scan. Materials and Methods: Twenty-one patients with unilateral obstructive uropathy were enrolled in this prospective comparative study. They were subjected to 99m Tc - DTPA renal scan and 64 slice helical CT scan which estimates the renal volume depending on the reconstruction of arterial phase images followed by volume rendering and percent renal volume was calculated. Percent renal volume was correlated with percent renal function, as determined by nuclear renal scan using Pearson coefficient. Results and Observation: A strong correlation is observed between percent renal volume and percent renal function in obstructed units (r = 0.828, P < 0.001) as well as in nonobstructed units (r = 0.827, P < 0.001). Conclusion: There is a strong correlation between percent renal volume determined by CT scan and percent renal function determined by 99m TC - DTPA renal scan both in obstructed and in normal units. CT-based percent renal volume can be used as a single radiological tests for both functional and anatomical assessment of impaired renal units.